Abstract
Abiola Senok, Subham Verma, Lobna Mohamed, Eveline Kaambo, Syrine Boucherabine, Madikay Senghore, Anju Nabi, Maya Habous, Fouzia Jabeen, Adnan Alatoom, Najiba Abdulrazzaq, Danesh Moradigaravand, Wafaa Jamal, Rania Nassar, Eiman Mokaddas, Dean B. Everett
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis
10.1371/journal.pone.0177113 · 2017
Early signals of vaccine-driven perturbation seen in pneumococcal carriage population genomic data
10.1093/cid/ciz404 · 2020
Capsular polysaccharide (CPS) release by serotype 3 pneumococcal strains reduces the protective effect of anti-type 3 CPS antibodies
10.1128/cvi.00591-15 · 2016
Performance standards for antimicrobial susceptibility testing
2023
Rapid pneumococcal evolution in response to clinical interventions
10.1126/science.1198545 · 2011
Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins
10.1093/nar/gku1196 · 2015
Decline in pneumococcal nasopharyngeal carriage of vaccine serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine in children in Atlanta, Georgia
10.1097/inf.0000000000000849 · 2015
International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact
10.2139/ssrn.3360095 · 2019
Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event
10.1038/ng.1072 · 2012
Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain
10.1016/j.cmi.2019.10.034 · 2020
Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries
10.1080/13696998.2021.1970975 · 2021
Nonencapsulated Streptococcus pneumoniae: Emergence and pathogenesis
10.1128/mbio.01792-15 · 2016
Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: A United States perspective
10.1128/cmr.00058-15 · 2016
Use of 21-valent pneumococcal conjugate vaccine among U.S. adults: Recommendations of the Advisory Committee on Immunization Practices - United States 2024
10.15585/mmwr.mm7336a3 · 2024
Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: An international whole-genome sequencing study
10.1016/s1473-3099(19)30297-x · 2019
Sugar-coated killer: Serotype 3 pneumococcal disease
10.3389/fcimb.2020.613287 · 2020
Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction, (2011-2016): Surveillance data from 23 sites in Catalonia, Spain
10.1371/journal.pone.0228612 · 2020
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance
10.1111/j.1469-0691.2011.03570.x · 2012
Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine
10.1016/j.diagmicrobio.2014.05.020 · 2014
Invasive pneumococcal disease in the Gulf region: A narrative review of incidence, burden, and vaccine strategies
10.3389/fpubh.2025.1589366 · 2025
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: Analysis of multisite, population-based surveillance
10.1016/s1473-3099(14)71081-3 · 2015
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates
10.1016/s0140-6736(09)61204-6 · 2009
Whole-genome analysis revealed antimicrobial resistance and virulence-associated genome features in environmental Salmonella enterica isolates from creek sediments in the Mid-Atlantic United States
10.3390/microbiolres17040072 · 2026
Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States
10.1128/aac.03344-14 · 2014
Emergence of Streptococcus pneumoniae serotype 12F after sequential introduction of 7- and 13-valent vaccines, Israel
10.3201/eid2403.170769 · 2018
Antimicrobial resistance in Streptococcus pneumoniae: A retrospective analysis of emerging trends in the United Arab Emirates from 2010 to 2021
10.3389/fpubh.2023.1244357 · 2023
Rebound of pediatric invasive pneumococcal disease in Portugal after the COVID-19 pandemic was not associated with significant serotype changes
10.1016/j.jinf.2024.106242 · 2024
Invasive pneumococcal disease in adults in Portugal: The importance of serotypes 8 and 3 (2015-2018)
10.3390/microorganisms9051016 · 2021
Genomic surveillance of invasive Streptococcus pneumoniae strains in South Tunisia during 2012-2022
10.1099/mgen.0.001448 · 2025
Serotype replacement in disease after pneumococcal vaccination
10.1016/s0140-6736(10)62225-8 · 2011
Validation and application of long-read whole-genome sequencing for antimicrobial resistance gene detection and antimicrobial susceptibility testing
10.1128/aac.01072-22 · 2023
Pneumococcal capsular switching: A historical perspective
10.1093/infdis/jis703 · 2013
Serotype distribution and antimicrobial resistance in pediatric invasive pneumococcal pneumonia: A laboratory surveillance study from Argentina 2022-2024
10.1016/j.vaccine.2025.128128 · 2026
No additional external references are available.